Chemotherapy of Malignancy

Post on 06-Apr-2018

222 views 0 download

Transcript of Chemotherapy of Malignancy

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 1/40

Click to edit Master subtitle style

5/2/12  

Chemotherapy Of Malignancy

BHARAT INSTITUTE OF TECNOLOGY

Mr.B.CHAKRAPANI M.pharm (ph.D)ASSISTANT PROFESSOR

DEPARTMENT OF PHARMACOLOGY

MANGALAPALLY,IBRAHIMPATNAM(M), R.R Dist.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 2/40

5/2/12  

qChemotherapy is a common treatment for a variety of cancers.

qIt has proven to be safe and effective.

qAn understanding of this treatment helps patients

 better recognize and tolerate side effects, if they occur 

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 3/40

5/2/12  

qAntineoplastic agents  are used in an attempt to

destroy tumor cells by interfering with cellular functions including replication.

qChemotherapy  is used primarily to treatsystemic disease rather than localized lesions thatare amenable to surgery or radiation.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 4/40

5/2/12  

qTo understand how chemotherapy works as a treatment,it is helpful to understand the normal life cycle of a cell inthe body.

qAll living tissue is composed of cells. Cells grow andreproduce to replace cells lost during injury or normal"wear and tear." The cell cycle is a series of steps that

 both normal cells and cancer cells go through in order toform new cells.

Working

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 5/40

5/2/12  

q Assess fluid and electrolyte status(Anorexia, nausea & vomiting,altered taste and diarrhea put patient

at risk)q Modifying risk for infection and

 bleeding(suppression of the bone marrowand immune system)

qAdministering Chemotherapypatient is observed for extravasation

(particularly of vesicant agents, whichmay produce necrosis if deposited in

subcutaneous tissuesØProtect caregivers

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 6/40

5/2/12  

Nursing Management in

Chemotherapy

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 7/40

5/2/12  

CELL CYCLE

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 8/40

5/2/12  

The cell cycle phases are:resting (G0; nothing ishappening), G1 (or gap 1; agrowth phase), S (synthesis; thereplication of DNA occurs), G2(gap 2; another growth phase),

and M (mitosis; the actualdivision from 1 cell into 2).

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 9/40

5/2/12  

6-12 h

S G1

6-8 h

G2 M

3-4 h 1 h

Cell Cycle

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 10/40

5/2/12  

S PHASE

Ø S phase – the s phase is the phase during

which dna replication is occurring.

Ø Out of sight of most people’s ability to see, thedna is undergoing replication so, at the end

of the s phase, there would be two complete

sets of dna in the nucleus of that cell.

Ø In the s phase the cell has copied the contents

of its nucleus

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 11/40

5/2/12  

G2 PHASE

Ø G2 Phase- In this phase, the cell makes copies of the importantorganelles found in the cytoplasm.

Ø If a cell is going to divided, it needs enough mitochondria, (power  plants) endoplasmic reticulum, (highways) and so on to support itself after cell division.

Ø If there are not enough mitochondria in one of the new cells, that cellwill die and the main purpose of cell division, to make two cells out of one cell, will be for nothing.

Ø In G2 phase, the important organelles in the cytoplasm are copied toensure that the two new cells will have enough organelles each tosurvive.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 12/40

5/2/12  

G1 PHASE

Ø G1 Phase– This is the phase in which the cell

spends almost all of its time.

Ø It is the normal phase of the cell.Ø The cell is doing what ever that cell was

designed to do.

Ø For example: a skin cell would function as a skincell during G1 and a liver cell would function asa liver cell during G1.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 13/40

5/2/12  

PROPHASE

Ø Prophase – Spindle fibers form, Chromosomesshorten, thicken and become visible (under a

microscope) and the nuclear membrane beginsto dissolve.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 14/40

5/2/12  

METAPHASE

Ø Spindle fibers move the chromosomes, whichhave their copies wrapped around themselves, tothe middle of the nucleus and line them up.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 15/40

5/2/12  

M-PHASE

Ø M Phase- This phase is the phase during

which the nucleus divides into two nuclei.

Ø

There are four parts to this phase;1) PROPHASE,

2) METAPHASE,

3) ANAPHASE ,

4) TELOPHASE.

Ø)

At the end of the M Phase, there will

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 16/40

5/2/12  

ANAPHASE

Ø Spindle fibers shorten and pull the identicalchromosomes away from each other to theopposite side of the nucleus.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 17/40

5/2/12  

 TELOPHASE

Ø Spindle fibers dissolve, chromosomeslengthen out and become invisible again,nuclear membrane reforms around both sets of 

separated chromosomes.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 18/40

5/2/12  

CYTOKINESIS

Ø The cytoplasm divides leaving you with twoidentical cells, each with one nucleus.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 19/40

5/2/12  

qNEUROLOGIC SYSTEM•

Peripheral neuropathies•Loss of deep tendon reflexes•Paralytic ileus

qMISCELLANEOUS•Fatigue•Alopecia

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 20/40

5/2/12  

REPRODUCTIVE SYSTEM 

q

Take effective contraceptive precautions whenhaving chemotherapy, as the chemotherapy drugsmight harm the baby if pregnancy occurs.

In some women, chemotherapy brings on an earlymenopause. This may cause symptoms such as drynessof the vagina and a decreased interest in sex.

C f B l i di t l

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 21/40

5/2/12  Second years II-I

Cancer of Buccal mucosa invading extra-oraltissues following tobacco quid habit

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 22/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 23/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 24/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 25/40

5/2/12  Dr Suwas Darvekar

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 26/40

5/2/12  Dr Suwas Darvekar

Cancer of Tongue following tobacco consumption

Alveolar cancer after tobacco quid habit

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 27/40

5/2/12  Dr Suwas Darvekar

Alveolar cancer after tobacco quid habit

ORAL LEUCOPLAKIA PATCH

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 28/40

5/2/12  

ORAL LEUCOPLAKIA PATCH

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 29/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 30/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 31/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 32/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 33/40

5/2/12  

Diarrhea can also be a side effect of chemotherapy. Caused by the destruction of normal, dividing cells of the

gastrointestinal (GI) tract, diarrhea varies from patient to patient. It is better managed if treated early

RENAL SYSTEMRapid tumor cell lysis- increased urinary excretion of uric

acid, which can cause renal damage

Myelosuppression- depression of bone marrowfunction, resulting in decreased production of blood

cells.- Decreases the number of RBCs (anemia), WBCs

(leukopenia) and platelets (thrombocytopenia)

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 34/40

5/2/12  

Nausea & Vomiting- most common sideeffects of chemotherapy and may persist for as

long as 24-48 hrs. after its administration.

Mucositis –  inflammation of the mucosallining

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 35/40

5/2/12  

qIt can cause irritation which can eventually lead toinflammation of the mouth, a condition known asstomatitis .

qA stinging sensation in the throat may develop andlead to dysphagia (difficulty in swallowing).

Management:qGood oral hygiene

GASTROINTESTINALSYSTEM

h h id ff f

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 36/40

5/2/12  

What are the side effects of Chemotherapy?

SKINAlopecia

q Hair loss occurs because

chemotherapy cansometimes damage healthycells.

q It is so common because

hair follicle cells multiplyvery quickly like cancer cells and chemotherapydrugs have difficulty indiscerning the difference.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 37/40

5/2/12  

Sequence of treatments:

qAdjuvant therapy: Therapy given after surgeryto reduce the likelihood of the cancer returning.

q Neo-adjuvant therapy: Therapy given before

surgery to shrink the tumor, allowing thesurgery to be more successful.

qConcurrent therapy: When 2 or more therapiesare given together, such as chemotherapy and

radiation.

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 38/40

5/2/12  

qOrally (by mouth, in pill form)qIntravenously (IV, through a vein, either as a short infusion or continuously for oneor more days)

qAs an injection or needleqDirectly into a body cavity (i.e.: the

 bladder, abdominal cavity)qIntra-arterially (in special cases, such aslimb perfusion treatment for melanoma)

How is chemotherapy given?

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 39/40

5/2/12  

8/3/2019 Chemotherapy of Malignancy

http://slidepdf.com/reader/full/chemotherapy-of-malignancy 40/40

5/2/12

Rand 50.3